Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1923]
News [3529]
Articles [90]
Editorials [5]
Conferences [156]
elearning [19]
ASCO 2023: Antibody-microtubule inhibitor conjugate improves survival in women with recurrent ovarian cancer
ASCO 2023: Antibody-microtubule inhibitor conjugate improves survival in women with recurrent ovarian cancer
ASCO 2023: Phase 3 trial demonstrates one-year PFS in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma who received a checkpoint inhibitor combined with chemotherapy
ASCO 2023: Phase 3 trial demonstrates one-year PFS in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma...
ASCO 2023: Nivolumab reduces risk of disease progression or death in untreated hodgkin lymphoma compared to brentuximab
ASCO 2023: Nivolumab reduces risk of disease progression or death in untreated hodgkin lymphoma compared to...
ASCO 2023: Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer
ASCO 2023: Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer
ASCO 2023: For advanced, HER2-amplified bile duct cancers, antibody treatment trial shows promising results
ASCO 2023: For advanced, HER2-amplified bile duct cancers, antibody treatment trial shows promising results
ASCO 2023: Immunotherapy for brain cancer metastases shows clinical benefit
ASCO 2023: Immunotherapy for brain cancer metastases shows clinical benefit
Initiative will test new drug combinations guided by tumour biology
Initiative will test new drug combinations guided by tumour biology
Researchers uncover potential novel therapeutic targets against natural killer/T-cell lymphoma
Researchers uncover potential novel therapeutic targets against natural killer/T-cell lymphoma
Pan-cancer T cell atlas reveals new details of tumour microenvironment
Pan-cancer T cell atlas reveals new details of tumour microenvironment
Blocking a key immune protein improves radiation therapy for cancer
Blocking a key immune protein improves radiation therapy for cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation